Takip et
Sahin Lacin
Sahin Lacin
Koc University Faculty of Medicine
kuh.ku.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma
MM Hassan, G Botrus, R Abdel-Wahab, RA Wolff, D Li, D Tweardy, ...
Clinical Gastroenterology and Hepatology 15 (11), 1791-1799, 2017
1082017
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
AO Kaseb, M Hassan, S Lacin, R Abdel-Wahab, HM Amin, A Shalaby, ...
Oncotarget 7 (43), 69916, 2016
502016
Analysis of FUSOBACTERIUM NUCLEATUM and Streptococcus Gallolyticus in Saliva of Colorectal Cancer Patients
DC Guven, O Dizdar, A Alp, FN Akdoğan Kittana, D Karakoc, ...
Biomarkers in Medicine 13 (9), 725-735, 2019
362019
Recent advances in the management of pancreatic adenocarcinoma
Y Karakas, S Lacin, S Yalcin
Expert review of anticancer therapy 18 (1), 51-62, 2018
312018
The prognostic value of circulating VEGF-A level in patients with hepatocellular cancer
S Lacin, S Yalcin
Technology in Cancer Research & Treatment 19, 1533033820971677, 2020
282020
Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: a case report
B Baran, C Karaca, OM Soyer, S Lacin, K Demir, F Besisik, G Boztas
Clinics and research in hepatology and gastroenterology 36 (4), e69-e70, 2012
242012
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study
N Akdeniz, MA Kaplan, D Uncu, M İnanç, S Kaya, F Dane, M Küçüköner, ...
International Journal of Colorectal Disease 36, 1311-1319, 2021
202021
Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen
S Lacin, E Esin, Y Karakas, S Yalcin
OncoTargets and therapy, 1039-1042, 2015
172015
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?
M Ayhan, Ş Laçin, DT Özyükseler, H Sürmeli, A Doğan, M Turan, ...
Journal of Oncology Pharmacy Practice 27 (6), 1461-1467, 2021
122021
Protective effects of taxifolin on pazopanib-induced liver toxicity: an experimental rat model
B Akagunduz, M Ozer, F Ozcıcek, AV Kara, S LAcın, M Özkaraca, ...
Experimental animals 70 (2), 169-176, 2021
122021
Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma
S Paydas, S Lacin, M Dogan, I Barista, B Yildiz, G Seydaoglu, ...
Leukemia Research 107, 106586, 2021
112021
Impact of integrating insulin-like growth factor 1 levels into model for end-stage liver disease score for survival prediction in hepatocellular carcinoma patients
R Abdel-Wahab, MM Hassan, B George, R Carmagnani Pestana, L Xiao, ...
Oncology 98 (12), 836-846, 2020
112020
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
MA Ali, S Lacin, R Abdel-Wahab, M Uemura, M Hassan, A Rashid, ...
OncoTargets and therapy, 1403-1412, 2017
112017
A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer
Y Karakas, E Esin, S Lacin, K Ceyhan, AO Heper, S Yalcin
OncoTargets and therapy, 4815-4820, 2016
102016
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy
Z Yan, L Li, D Fu, W Wu, N Qiao, Y Huang, L Jiang, D Wu, Y Hu, H Zhang, ...
Frontiers of Medicine 17 (4), 699-713, 2023
92023
Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing
K Agiannitopoulos, K Potska, A Katseli, C Ntogka, GN Tsaousis, G Pepe, ...
Cancers 15 (21), 5218, 2023
72023
The effect of exercise on disease-free survival and overall survival in patients with breast cancer
N Akdeniz, MA Kaplan, M Küçüköner, Z Urakçı, Ş Laçin, EH Ceylan, ...
Irish Journal of Medical Science (1971-), 1-11, 2021
72021
Prognostic significance of serum insulin-like growth factor-1 in hepatocellular cancer patients: a validation study
S Lacin, S Yalcin, Y Karakas, MM Hassan, H Amin, YI Mohamed, ...
Journal of Hepatocellular Carcinoma, 143-153, 2020
72020
Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers
Y Karakas, N Kertmen, S Lacin, A Aslan, M Demir, O Ates, S Aksoy, ...
Age 24, 0.63, 2017
72017
Metastatic ameloblastoma to the liver: rare presentation of a rare disease
S Lacin, A Dogrul, E Dikmen, N Kertmen, A Turker, A Kars
J Clin Case Rep 9 (1207), 2, 2019
62019
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20